Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

June 5, 2002

By Aaron Lorenzo

Alliance Gets Approval For Ultrasound Imaging Agent

June 4, 2002

By Aaron Lorenzo

Alliance Gets Approval For Ultrasound Imaging Agent

June 4, 2002

By Aaron Lorenzo

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

June 3, 2002

By Aaron Lorenzo

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

June 3, 2002

By Aaron Lorenzo

Visible Genetics Considers Sale Of Company, Lowers Estimates

May 31, 2002

By Aaron Lorenzo

Visible Genetics Considers Sale Of Company, Lowers Estimates

May 31, 2002

By Aaron Lorenzo

Serenex Rationalizing Proteomics To Find, Revitalize Compounds

May 29, 2002

By Aaron Lorenzo

Serenex Rationalizing Proteomics To Find, Revitalize Compounds

May 29, 2002

By Aaron Lorenzo

Tercica Raises $21.5M, Gains Rights To IGF-1 From Genentech

May 24, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...